Austedo's drug class is a vmat2 inhibitor (vesicular monoamine transporter 2 inhibitor) Austedo typically starts at 6 mg twice daily. What is tardive dyskinesia (td) and chorea associated with huntington’s disease
OnlyFans
Austedo (deutetrabenazine) is a prescription drug used to treat tardive dyskinesia and chorea related to huntington’s disease
The drug comes in two forms
This article describes the dosages of austedo, as well as its strengths and how to take it. Length of therapy (in days) ☐ up to 30 days ☐ 60 days ☐ 90 days ☐ 120 days ☐ 180 days s clinical information tardive dyskinesia T e beneficiary have a diagnosis of moderate e ☐ no 2
Is the beneficiary age 18 or older The most common adverse reactions for austedo (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis and insomnia Austedo and austedo xr treat tardive dyskinesia and chorea related to huntington’s disease in adults The dosage varies depending on the condition
